The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Novel Experimental Agents for the Treatment of Hypercholesterolemia
|
---|---|
Published in |
Journal of experimental pharmacology, February 2021
|
DOI | 10.2147/jep.s267376 |
Pubmed ID | |
Authors |
Ivan Pećin, Željko Reiner |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Dominican Republic | 1 | 7% |
United States | 1 | 7% |
Finland | 1 | 7% |
Unknown | 11 | 79% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 9 | 64% |
Scientists | 2 | 14% |
Practitioners (doctors, other healthcare professionals) | 2 | 14% |
Science communicators (journalists, bloggers, editors) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 44 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 8 | 18% |
Student > Postgraduate | 3 | 7% |
Researcher | 3 | 7% |
Student > Bachelor | 2 | 5% |
Librarian | 2 | 5% |
Other | 5 | 11% |
Unknown | 21 | 48% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 9 | 20% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 9% |
Chemistry | 3 | 7% |
Nursing and Health Professions | 2 | 5% |
Unspecified | 2 | 5% |
Other | 3 | 7% |
Unknown | 21 | 48% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 April 2021.
All research outputs
#4,304,335
of 25,387,668 outputs
Outputs from Journal of experimental pharmacology
#20
of 150 outputs
Outputs of similar age
#112,170
of 526,732 outputs
Outputs of similar age from Journal of experimental pharmacology
#6
of 19 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 150 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 526,732 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.